A detailed history of Generate Investment Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Generate Investment Management LTD holds 15,632 shares of LLY stock, worth $11.7 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
15,632
Previous 28,128 44.43%
Holding current value
$11.7 Million
Previous $25.5 Billion 45.62%
% of portfolio
0.93%
Previous 1.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$772.14 - $960.02 $9.65 Million - $12 Million
-12,496 Reduced 44.43%
15,632 $13.8 Billion
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $2.31 Million - $2.9 Million
-3,187 Reduced 10.18%
28,128 $25.5 Billion
Q1 2024

Aug 01, 2024

SELL
$592.2 - $792.28 $4.73 Million - $6.33 Million
-7,984 Reduced 20.32%
31,315 $24.4 Billion
Q4 2023

Aug 01, 2024

BUY
$525.19 - $619.13 $20.6 Million - $24.3 Million
39,299 New
39,299 $22.9 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Generate Investment Management LTD Portfolio

Follow Generate Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generate Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Generate Investment Management LTD with notifications on news.